8-K//Current report
Apimeds Pharmaceuticals US, Inc. 8-K
Accession 0001213900-25-112184
$APUSCIK 0001894525operating
Filed
Nov 17, 7:00 PM ET
Accepted
Nov 18, 4:57 PM ET
Size
203.8 KB
Accession
0001213900-25-112184
Documents
- 8-Kea0266166-8k_apimeds.htmPrimary
CURRENT REPORT
- EX-10.1ea026616601ex10-1_apimeds.htm
AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT, DATED NOVEMBER 13, 2025
- EX-101.SCHapus-20251113.xsd
XBRL SCHEMA FILE
- EX-101.LABapus-20251113_lab.xml
XBRL LABEL FILE
- EX-101.PREapus-20251113_pre.xml
XBRL PRESENTATION FILE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001213900-25-112184-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLea0266166-8k_apimeds_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Apimeds Pharmaceuticals US, Inc.
CIK 0001894525
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001894525
Filing Metadata
- Form type
- 8-K
- Filed
- Nov 17, 7:00 PM ET
- Accepted
- Nov 18, 4:57 PM ET
- Size
- 203.8 KB